{
  "paper_metadata": {
    "pmid": "35419651",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.238A>G",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Not specified",
        "phenotype": "Mixed/CM/PNC"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": [
          {
            "age_range": "50+ years",
            "penetrance_percentage": 40.0,
            "carriers_in_range": 10,
            "affected_in_range": 4
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 55,
          "age_at_onset": 50,
          "age_at_diagnosis": 52,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Cardiomyopathy",
          "evidence_sentence": "Patient P1 was diagnosed at age 52 with cardiomyopathy."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 60,
          "age_at_onset": 55,
          "age_at_diagnosis": 58,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Polyneuropathy",
          "evidence_sentence": "Patient P2 was diagnosed at age 58 with polyneuropathy."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 50,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms",
          "evidence_sentence": "Patient P3 is a carrier but remains asymptomatic."
        }
      ],
      "functional_data": {
        "summary": "Functional assays indicate that the T80A variant leads to reduced protein stability.",
        "assays": [
          "In vitro stability assays",
          "Functional assays measuring amyloid formation"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Not specified",
      "evidence_level": "Moderate",
      "source_location": "Table 1, Row 1",
      "additional_notes": "The penetrance of the T80A variant is variable among carriers.",
      "key_quotes": [
        "The exact penetrance of each variant is currently unknown and incomplete penetrance is frequent."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.148G>A",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Not specified",
        "phenotype": "Mixed"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 2,
        "unaffected_count": 8,
        "uncertain_count": null,
        "penetrance_percentage": 20.0,
        "age_dependent_penetrance": [
          {
            "age_range": "50+ years",
            "penetrance_percentage": 20.0,
            "carriers_in_range": 10,
            "affected_in_range": 2
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P4",
          "age_at_evaluation": 65,
          "age_at_onset": 60,
          "age_at_diagnosis": 62,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Cardiomyopathy",
          "evidence_sentence": "Patient P4 was diagnosed at age 62 with cardiomyopathy."
        },
        {
          "individual_id": "P5",
          "age_at_evaluation": 70,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms",
          "evidence_sentence": "Patient P5 is a carrier but remains asymptomatic."
        }
      ],
      "functional_data": {
        "summary": "Functional assays suggest that the V50M variant may lead to altered protein folding.",
        "assays": [
          "In vitro folding assays",
          "Amyloidogenicity assays"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Not specified",
      "evidence_level": "Moderate",
      "source_location": "Table 1, Row 2",
      "additional_notes": "The penetrance of the V50M variant is variable among carriers.",
      "key_quotes": [
        "The exact penetrance of each variant is currently unknown and incomplete penetrance is frequent."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Common hATTR amyloidosis pathogenic variants in Ireland and the UK",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text and tables."
  }
}